Trilliome is at ARDD 2026, the 13th Aging Research & Drug Discovery Meeting, held at Harvard's David Rubenstein Treehouse in Boston from 1 to 3 October. We return after placing second in last year's startup competition.
On day one, XPRIZE Healthspan presented its finalists. Among the 61 finalist applicants, nutraceuticals and supplements were the most common approach (57% of teams), and 40% of the 10 teams just awarded a further USD 10M work with them. The leading targets were metabolism and immune and inflammation, two systems the gut's bacteria help run.
Patrick is in Boston until Saturday. To meet him, get in touch.